These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12757727)

  • 21. Alpha-cyanocinnamide derivatives: a new family of non-peptide, non-sulfhydryl inhibitors of Ras farnesylation.
    Poradosu E; Gazit A; Reuveni H; Levitzki A
    Bioorg Med Chem; 1999 Aug; 7(8):1727-36. PubMed ID: 10482464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.
    Carboni JM; Yan N; Cox AD; Bustelo X; Graham SM; Lynch MJ; Weinmann R; Seizinger BR; Der CJ; Barbacid M
    Oncogene; 1995 May; 10(10):1905-13. PubMed ID: 7761092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Arylalkyl pseudopeptide inhibitors of farnesyltransferase.
    deSolms SJ; Giuliani EA; Graham SL; Koblan KS; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Scholz TH; Wiscount CM; Gibbs JB; Smith RL
    J Med Chem; 1998 Jul; 41(14):2651-6. PubMed ID: 9651171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CAAX peptidomimetics: their farnesyltransferase inhibition activity and antitumor effect].
    Ohkanda J
    Seikagaku; 2002 Jan; 74(1):46-50. PubMed ID: 11889772
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase.
    Burns CJ; Guitton JD; Baudoin B; Lelièvre Y; Duchesne M; Parker F; Fromage N; Commerçon A
    J Med Chem; 1997 Jun; 40(12):1763-7. PubMed ID: 9191950
    [No Abstract]   [Full Text] [Related]  

  • 26. CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents.
    Omer CA; Kohl NE
    Trends Pharmacol Sci; 1997 Nov; 18(11):437-44. PubMed ID: 9426472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
    Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Aryl-4-aryloyl-1-(1H-imidazol-5-yl)methylpyrrole, a novel class of farnesyltransferase inhibitors.
    Lee H; Lee J; Shin Y; Jung W; Kim JH; Park K; Ro S; Chung HH; Koh JS
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2963-5. PubMed ID: 11677136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells.
    Mazet JL; Padieu M; Osman H; Maume G; Mailliet P; Dereu N; Hamilton AD; Lavelle F; Sebti SM; Maume BF
    FEBS Lett; 1999 Oct; 460(2):235-40. PubMed ID: 10544242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase.
    Ding CZ; Batorsky R; Bhide R; Chao HJ; Cho Y; Chong S; Gullo-Brown J; Guo P; Kim SH; Lee F; Leftheris K; Miller A; Mitt T; Patel M; Penhallow BA; Ricca C; Rose WC; Schmidt R; Slusarchyk WA; Vite G; Yan N; Manne V; Hunt JT
    J Med Chem; 1999 Dec; 42(25):5241-53. PubMed ID: 10602709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein farnesyltransferase inhibitors.
    Ayral-Kaloustian S; Salaski EJ
    Curr Med Chem; 2002 May; 9(10):1003-32. PubMed ID: 12733981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors.
    Ding CZ; Hunt JT; Ricca C; Manne V
    Bioorg Med Chem Lett; 2000 Feb; 10(3):273-5. PubMed ID: 10698452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different amino acid replacements in CAAX-tetrapeptide based peptidomimetic farnesyltransferase inhibitors.
    Schlitzer M; Sattler I; Dahse HM
    Arch Pharm (Weinheim); 1999 Apr; 332(4):124-32. PubMed ID: 10327885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-thiol farnesyltransferase inhibitors: N-(4-Acylamino-3-benzoylphenyl)-4-nitrocinnamic acid amides.
    Sakowski J; Sattler I; Schlitzer M
    Bioorg Med Chem; 2002 Feb; 10(2):233-9. PubMed ID: 11741771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of conformationally constrained 5,6,7, 8-Tetrahydroimidazo[1,5-a]pyridine inhibitors of farnesyltransferase.
    Dinsmore CJ; Zartman CB; Baginsky WF; O'Neill TJ; Koblan KS; Chen IW; McLoughlin DA; Olah TV; Huff JR
    Org Lett; 2000 Nov; 2(22):3473-6. PubMed ID: 11082012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.
    Bergman JM; Abrams MT; Davide JP; Greenberg IB; Robinson RG; Buser CA; Huber HE; Koblan KS; Kohl NE; Lobell RB; Graham SL; Hartman GD; Williams TM; Dinsmore CJ
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1411-5. PubMed ID: 11378366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of a novel series of farnesyl protein transferase inhibitors as non-peptidic CAAX tetrapeptide analogues.
    Perez M; Maraval C; Dumond S; Lamothe M; Schambel P; Etiévant C; Hill B
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1455-8. PubMed ID: 12668011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of homofarnesoyl-substituted CAAX-peptidomimetics as farnesyltransferase inhibitors and antiproliferative agents.
    Schlitzer M; Sattler I; Dahse HM
    Bioorg Med Chem; 1999 Sep; 7(9):2037-45. PubMed ID: 10530953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides.
    Mitsch A; Wissner P; Silber K; Haebel P; Sattler I; Klebe G; Schlitzer M
    Bioorg Med Chem; 2004 Sep; 12(17):4585-600. PubMed ID: 15358286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.